HER2/neu Oncoprotein Overexpression in Epithelial Ovarian Cancer: Evaluation of its Prevalence and Prognostic Significance

Publisher： Karger

E-ISSN： 1423-0232|68|2-3|154-161

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.2-3, 2005-07, pp. : 154-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER2: The Neu Prognostic Marker for Breast Cancer

By Tsongalis Gregory J.   Ricci Jr. Andrew  

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 2, 1998-03 ,pp. : 167-182

Informa Healthcare

Access to resources Recommend Favorite

Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer

By  

Oncology, Vol. 88, Iss. 3, 2014-11 ,pp. : 147-156

Karger

Access to resources Recommend Favorite

Her-2/neu Overexpression Due to Polysomy 17 in Breast Cancer: Molecular Testing to Guide Therapeutic Options

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 356-360

Karger

Access to resources Recommend Favorite

Prognostic Values of p53 and HER-2/neu Coexpression in Invasive Bladder Cancer in Taiwan

By  

Urologia Internationalis, Vol. 71, Iss. 3, 2003-09 ,pp. : 262-270

Karger

Access to resources Recommend Favorite

Micrometastatic p53-Positive Cells in the Lymph Nodes of Early Stage Epithelial Ovarian Cancer: Prognostic Significance

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 170-175

Karger

Access to resources Recommend Favorite